Video summary

Week 02: Lecture 06: Introduction on Nanoparticles as Drug Delivery System-I

Main summary

Key takeaways

Educational

Main ideas and concepts (Lecture Overview)

  • Introduction to nanoparticles as drug delivery systems

    • Nanoparticles (1–100 nm) are framed as a key component of novel drug delivery systems.
    • The lecture highlights how nanotechnology enables “translation” of conventional drugs into nano-medicines for improved treatment.

  • Impact and broad applications of nanotechnology in healthcare and beyond

    • Nanotechnology is presented as influencing not only drug delivery, but also:
      • Therapeutics (e.g., converting anti-cancer drugs into nano-medicine forms; treating infectious diseases)
      • Diagnostics and sensors
      • Implants
      • Drug diagnostics
      • Reporter cell/organ platforms (as stated)
      • Environmental applications (e.g., wastewater treatment)
      • Cosmetics
      • Disinfection
      • Nutraceutical supplements
      • Biological models (cell, animal, and tissue culture development)
      • Pesticides (improving efficacy/efficiency via nano-based formulations)
      • Packaging and food processing materials
    • Key takeaway: nanotechnology is not limited to medicine/drug delivery only.

  • History and motivation

    • Richard Feynman is cited for proposing the concept of nanotechnology through the statement:

      “There is plenty of room at the bottom.”

    • The lecture notes that nanomaterials overlap with the size scale of many biological molecules and entities.

  • Why nanoscale is special

    • The lecture compares the sizes of:
      • Atoms, proteins, antibodies, viruses, bacteria, eukaryotic cells
      • with nanomaterials, stated to be in the ~1 to 100 nm range.
    • It also notes that nanoparticle visualization typically requires:
      • Scanning Electron Microscopy (SEM)
      • Transmission Electron Microscopy (TEM)
      • rather than conventional light microscopy.

Definition-focused concepts (Nano-medicine and nanotech terminology)

Nanomedicine (definition)

  • Nanomedicine is broadly defined as medicine using nanotechnology for:
    • disease prevention
    • monitoring
    • intervention (through new modalities)
    • imaging, diagnosis, treatment, repair, and regeneration of biological systems

Conventional drug limitations → why nanotechnology helps

  • Conventional formulations mentioned include:
    • capsules, tablets, syrups, pellets
  • Stated limitations include:
    • limited solubility
    • limited efficacy due to permeability
  • Nanotechnology advantage:
    • improves bioavailability
    • helps overcome solubility/permeability issues for oral drugs (described as rate-limiting steps)
    • converts particles from micron to nano size to enhance performance

Terminology used in nanotechnology

1) Nanoparticles

  • Small particles typically 1–100 nm
  • Have specific physicochemical properties that differ from bulk materials of the same composition
  • Size reduction (micron → nano) can change properties such as:
    • size
    • shape
    • surface area

2) Nano-based drug delivery

  • A concept where nano-formulations are delivered to the target site
  • Goal: deliver the drug payload (carrier payload) to:
    • the right place
    • the right time
    • the right optimal dose
  • After administration, the carrier targets the site and releases the drug there.

3) Nano systems

  • Described as submicron-sized particles
  • Size: below 1 micrometer
  • Contain one or more therapeutic agents that may be:
    • dispersed/absorbed on the surface
    • coherently bound
    • encapsulated in vesicles/capsules/matrices

4) Nanocarriers

  • Carriers that carry molecules (drugs, biologics, diagnostics) to specific sites in the body
  • Main role: carry and deliver payload to the target location
  • Example:
    • Polymerosomes that encapsulate anti-cancer drugs and preferentially deliver them to cancer cells (rather than normal cells)

5) Nanomaterials

  • Nanotechnology materials produced using different material classes such as:
    • lipids
    • inorganic materials
    • polymers
    • surfactants
  • These combine to create nano materials

Categories and types of nanoparticles / nanocarrier systems

A) By material class: organic vs inorganic

  • Organic nanomaterials

    • Contain carbon and hydrogen atoms
    • Examples mentioned:
      • liposomes
      • polymeric nanoparticles
      • micelles
      • dendrimers
      • lipid nanoparticles
    • Property noted:
      • may form via self-assembly systems, including under conditions such as:
        • applying pressure (as stated)
        • interactions (including opposite charges) that lead to self-assembled nanostructures

  • Inorganic nanomaterials

    • Do not contain carbon and hydrogen in their structure
    • Comprised of metallic/non-metallic elemental compounds
    • Examples mentioned:
      • quantum dots
      • nanoceria
      • iron oxide nanoparticles
      • gold nanoparticles
      • silica nanoparticles
      • silver nanoparticles
    • These are described as based on metal/metal oxides and related materials.

B) Nanocarrier examples referenced (grouped as mentioned)

  • Polymer-based systems
    • polymeric micelles
    • polymerosomes
  • Lipid-based systems
    • micelles
    • dendrimers
    • solid lipid nanoparticles (SLN)
    • liposomes
    • lipid nanoparticles
    • extracellular vesicles
  • Inorganic systems
    • silica
    • silver
    • gold

Properties of nanoparticles (main points)

  • Distinct physicochemical properties vs bulk

    • Nano-scale materials exhibit properties different from bulk materials.

  • Key properties highlighted

    • Very small size
      • stated as < 1 micron, preferably 10–100 nm
    • High surface area
      • smaller particles → larger surface area relative to volume
      • used to convert water-insoluble drugs into more water-soluble forms (via increased surface area)
    • Surface chemistry can be modified
      • modify with polymers to enhance:
        • biocompatibility
        • drug binding
      • functionalize with molecules (e.g., ligands) for receptor-specific targeting (example: cancer targeting)
      • load drug molecules to control release
      • add fluorescent molecules for imaging
    • Improved suspension in liquids
      • nanoparticles are stated to suspend more easily than bulk materials, improving solubility
    • Better cellular penetration
      • due to size reduction, nanoparticles can reach deeper into cells and even target:
        • organelles (example: mitochondria)
    • Inorganic materials for imaging
      • can provide optical, magnetic, electrical properties
      • used as contrasting agents in MRI and CT (as stated)

Lecture structure / progression (what the instructor planned to cover)

  1. Introduction to nanoparticles as drug delivery systems
  2. History behind nanoparticle development for drug delivery
  3. Definition/overview of nanomedicines
  4. Nanotechnology-related terminology (nanoparticles, nano-based drug delivery, nano systems, nanocarriers, nanomaterials)
  5. Types/categories of nanocarriers (organic vs inorganic + examples)
  6. Properties of nanoparticles as drug delivery tools

Concluding note:

  • Next class will cover advantages and applications, and case studies for each type.

Speakers / sources featured

  • Dr. Satish Dawanapelli — Instructor
    • Assistant Professor, Department of Pharmaceutical Sciences and Technology, Institute of Mumbai (spelled inconsistently in subtitles)
  • Richard Feynman — Historical source referenced
    • Nobel Prize mentioned as 1959
    • Quote: “There is plenty of room at the bottom”

Original video